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ABSTRACT 
Over the past decades major focus has been given towards innovative drug delivery systems and new dosage forms. This is due to highly expensive 
process and high attrition rates of existing marketed drugs. Hard-boiled lozenges (HBLs) are one of the solid dosage form designed to release the 
drug in saliva for either local or systemic effects. Typical application of lozenegs includes throat infection, pharyngitis, cough suppressant, nasal-
decongestant, expectorants, and smoking cessation. The drug delivery through the hard-boiled candies has an easy marketing advantage due to its 
attractive appearance and patient compliance. As a part of the drug is absosrbed into systemic circulation, gastrointestinal degradation and fast pass 
effects are avoided. Further, drug delivery through hard-boiled lozenges can be potential platform for some of the suitable drug candidates. This 
review on hard-boiled lozenges discusses manufacturing process, characterization techniques, quality control, research studies and market 
potential of hard-boiled lozenges. The major databases searched were, PubMed, Wiley Online, Medline, Elsevier, Google scholar, Scopus, ACS, The 
Royal Society of Chemistry, SciFinder, Baidu Scholars, CNKI, web of science, Cochrane database, 
Keywords: Medicated hard-boiled lozenges, Herbal drug, Drug delivery, Dosage form, Formulation, Characterization 
US Patents, Espacenet and various business reviews. 
This review provides comprehensive information on hard-boiled lozenges that will help the pharmaceutical scientist from academia as well 
pharmaceutical industry to leverage the potential of this conventional dosage form for various herbal drugs and other pharmaceutical actives.  
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijap.2021v13i2.40165. Journal homepage: https://innovareacademics.in/journals/index.php/ijap  
 
INTRODUCTION 
The drug administration through the oral route is one of the most 
widely used and preferred way of drug delivery due to its several 
advantages such as safety, ease of administration, non-invasiveness, 
better patient compliance, acceptability and simplicity [1]. It has 
been estimated that out of the current marketed oral pharmaceutical 
constitutes largest portion pharmaceutical products of 62.02%, 
followed parenteral (22.43%), other route of drug delivery such as 
topical route (8.70%), mucosal drug delivery (5.22%), inhalation 
dosage form (1.21%) and others (0.42%) [2]. The results indicate 
that oral cavity is the most convenient site for administration of both 
locally and systemically acting drugs. The oral dosage form consists 
of both solid and liquid dosage forms, considered to be the first 
choice of drug delivery system for a newly developed drug due to 
flexibility in its formulation design. Solid oral dosage forms includes 
popular formats such as tablets, capsules and other dosage forms 
like powders, granules, fast dissolving tablets, oral dispersible films, 
while liquid oral dosage forms consist of syrups, drops, sprays, 
solutions, emulsion, suspension, dispersions, semisolids and soft 
gels [3-5]. There has been a numerous research work done in the 
field of various oral dosage forms. Regarding application of hard 
boiled lozeneges in drug delivery, to the best of our knowledge, 
there is no comprehensive review article published exploring this 
specific dosage form. So in this attempt this review will focus on 
research work and significance of hard boiled lozenges (HBL) as a 
solid dosage form for drug delivery.  
Lozenges are defined as flavoured solid unit-dosage form of drug 
delivery usually designed to hold in oral cavity and wetted with 
saliva and slowly dissolved until complete dissolution. It is used both 
for local action of drugs in the mouth and pharynx for sore throat or 
pharyngitis and for systemic action such as pain relief and antacid. 
The lozenges are defined as hard solid, unit-dosage forms intended 
to slowly dissolve or disintegrate in the oral cavity [6-9]. There are 
several types of lozenges such as chewy, caramel, compressed tablet 
lozenges, soft lozenges, hard boiled lozenges classified on the basis 
of texture and composition [10, 11]. The hard lozenges are either 
sugar based or sugar-free formulations introduced around the year 
1970. Hard boiled lozenges (HBL) also known as Hard Boiled 
Candies (HBC) represents the most common and popular products 
within consumers. A typical hard boiled lozenge is 2 to 3 g in weight 
with a diverse size, shape, colour and flavours. These are generally 
made from hydrophilic water soluble substances such as sucrose, 
dextrose, liquid glucose or sugar free and low calorie based 
materials like isomalt, sorbitol or mannitol [12, 13].  
Advantages of hard boiled lozenges  
The administration of the hard boiled lozenges has better consumer 
preference due to their great taste, aroma, flavour, and elegant 
appearance with attractive colours. Further flavoured and 
sweetened lozenges help in masking bitter and unpleasant taste of 
active drugs substance. It has good acceptance among patients 
having difficulty in swallowing. It is safe to administer with ease of 
accessibility and removal. For taking lozenges it does not need 
additional water for administration and can be taken anywhere. As it 
is made up of highly hydrophilic materials such as sugar, liquid 
glucose or isomalt it gets dissolved easily which leads to quick onset 
of action. Further large surface area of oral cavity helps in rapid 
disintegration and dissolution. In addition, high blood supply and 
permeability of oral mucosa leads to quick absorption and rapid 
onset of action [13, 14]. As part of drug absorption from lozenges 
takes place directly in buccal mucosa it provides better metabolic 
and enzymatic stability to the drug and also reduces extent of gastric 
irritation. Further there is a less drug metabolism in buccal cavity 
due to reduced enzymatic activity of peptidase and protease [15]. 
The manufacturing process of HBL is a simple and easy with limited 
steps, less number of excipients, least expensive and solvent free 
process.  
However, the hard-boiled medicated lozenges are also having 
certain disadvantages like it might be appreciated by children as a 
confectionary so should be restricted from their access. There is a 
risk of choking and aspiration [15]. Due to high processing 
temperature during candy preparation thermolabile active 
ingredients are not stable in HBL formulation due to chances of their 
degradation and hydrolysis. The base used in the product 
manufacture should be having better flow properties. The drug 
should be having suitable physicochemical properties such as better 
solubility in saliva, and should be non-irritant on buccal mucosa. As 
continuous secretion of saliva is required for dissolving, it is not 
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suitable for patients having dry mouth syndrome with insufficient 
saliva. Sucking of acidic candies has also been reported to have 
erosive potential in mouth and cause gastrointestinal disturbances. 
It has been reported that excess consumption of isomalt is reported 
to cause laxative effect [16-18]. Frequent use of fentanyl citrate 
containing sucrose-based lozenges has been reported to cause 
severe dental caries [19]. A conventional lozenge initially releases 
the drug at higher rate that declines rapidly to below therapeutic 
label that leads to systemic toxicity and compliance [20]. As the 
menthol-based lozenges available as over-the-counter (OTC) 
medicines may worsen the severity of cough due to overuse [21].  
Some of the zinc lozenges have been reported with adverse effects 
like acute bad taste, which is commonly found to be reversed after 
discontinue of taking the same [22]. Potential drug interaction has 
been suspected between the common ingredients found in the cough 
drops such as eucalyptus oil, menthol and licorice with warferin due 
to their affinity towards cytochrome P450 and their ability to bind 
with albumin [23]. Moreover, other limitation are the comparatively 
small surface area available for drug absorption, shorter residence 
time of the dosage form in oral cavity due to simultaneous 
swallowing of drug with saliva. 
Challenges in bioavailability 
Poor oral bioavailability of new chemical entities (NCEs) continues to 
be the major obstacle against development of new drug formulation 
due to poor aqueous solubility. It has estimated that more than 40% of 
approved drug molecules developed from the process of drug 
discovery and 70% of drug molecules in development pipeline 
qualified as biopharmaceutical classification systems (BCS) class-II 
and Class IV. Low solubility of drugs candidates lead to poor 
bioavailability, inefficient formulation or attrition and failure from the 
developmental pipeline, which make an increase in cost of drug 
development for the inventors [24-27]. Many herbal-based drugs and 
extracts having excellent in vitro activity showed poor action in 
preclinical and clinical-stage due to their poor aqueous solubility. 
These remain as major obstacle in the developability of many 
botanicals and herbal extracts into suitable dosage forms [28].  
  
Table 1: List of some marketed lozenges 
S. No. Trade name  Active Ingredient  Developer  Indication  
1.  Drill Chlorhexidine-digluconate, tetracaine 
hydrochloride 
® Pierre Fabre-France Cough relief 
antimicrobial and antiviral  
2.  Horehound 
lozenges 
Marrubiumvulgare  Cough relief  
3.  Halls  Menthole, eucalyptus oil, hexylresorcino Mondelez 
International ,
 Cadbury-USA 
Antitussive, natural cough suppressant  
4.  VICKS P P cough 
drops  
Menthol  Procter and Gamble-
USA  
Antitussive: Throat lozenge for cough and 
sore throat-cough suppressant and oral  
5.  ZICAM cold 
remedy  
Zinc acetate, zinc gluconate and menthol   Cold, flu and allergies, to treat or reduce 
symptoms of the cold virus. 
6.  Strepsils 2,4-dichlorobenzyl alcohol, amylmetacresol, 
hexylresorcinol, flurbiprofen 
Reckitt Benckiser-UK Sore throat, viral infection, anti-
inflammatory actions, antiseptic, upper 
respiratory tract infection, analgesic. 
7.  Dorithricin Tyrothricin, benzalconium chloride, and 
banzocaine 
MEDICE Arzneimittel 
Pütter GmbH and Co. 
KG, Germany  
Throat pain, acute pharyngitis and sore 
throat, antiviral.  
8.  Koflet Ginger, pepper, clove, licorice Himalaya Drug 
company-India 
Pharyngitis, Laryngitis, respiratory tract 
disease  
9.  Hajmola Combination of digestive herbals extracts 
and powder  
Dabur-India Digestive  
10.  Bronchipret 
 
Thymus vulgaris), ivy (Hedera helix) or 
cowslip (Primula veris) 
Bionorica-Germany Common cold, respiratory inflammation 
and bronchitis  
11.  NT tuss Holy basil, turmeric, licorice, galangal, 
Vasaka 
Cadila Pharma Sore throat and cough  
12.  Golden Throat 
Lozenge 
Honey Suckle Flower (jin yin hua), 
Peppermint Oil, Eucalyptus Oil, Luo-Han-




Sore throat, halitosis and upper respiratory 
tract discomfort 
13.  Devilion Caffeine and taurine Devilion Energy Energy and sports  
14.  ViraBLOC® Elderberry extract  GNC Upper respiratory tract infections. 
15.  Sambucus 
Immune 
Lozenge 
Elder berry extract, Vitamic C, Zinc 
gluconate 
Nature's Way Immune support 
16.  Benadryl-DR 
cough lozenges  
Dextromethorphan Hydrobromide Johnson and Johnson  Dry cough and throat irritation  
17.  Strepsils 
Intensive 
Flurbiprofen Reckitt Benckiser Pain relief from sore throat  




Pain and inflammation in the throat 
19.  Cepacol Menthol and Benzocaine Adcock Ingram Sore throat and throat pain  
20.  Medi-Keel A cetylpyridinium chloride, benzocaine Adcock Ingram Sore throat  
21.  Goldex throat 
lollies  
Cetylpyridinium Chloride Goldex healthcare  Sore throat, tonsilitis, laryngitis 
22.  EpiCor® Throat 
Lozenges 





23.  AllergEase Nettle, eyebright, elderflower, plantain, 
vitamin C, and menthol 
AllergEase LLC Seasonal allergies, immune supports 
24.  PhytoRelief-CC Contains Turmeric, Pomegranate and 
Ginger 
Alchemlife  Cold, Flu and immune health.  
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Some of the examples are bioactive molecules of natural origin for 
example, oleanolic acid, artemether, piperine, quercetin and 
andrographolide that have poor bioavailability due to low water 
solubility and high first-pass metabolism [29-31]. As discovery and 
development of new chemical entities or new molecular entities 
(NCEs/NMEs) is a very complex, difficult, expensive and time-
consuming process, there is need of advanced or novel drug delivery 
technology for the drug candidates with poor bioavailability [3]. This 
will reduce the high attrition of molecules from the developmental 
pipeline resulting in success and value creation for innovators [27]. 
Therefore, there is an urgent need to develop alternative 
formulations that will enhance solubility, bioavailability, taste 
masking and patient compliance. The commonly used drug delivery 
strategies to enhance the solubility of low polar drugs are making 
salt forms of drugs, use of co-solvents, drug-complexes, liposomal 
drug delivery, micronization, microemulsion, and solid dispersion 
[31]. Hard-boiled lozenges (HBL), which are made by homogenous 
mixing of the drug in the sugar-based or sugar-free molten base, may 
be a potential solution for development of formulation with 
improved solubility for thermo-stable drugs with high melting point 
and poor water solubility. In HBL the drug is dispersed in molten 
base by molecular mixing to make amorphous solid dispersion. 
Current business review on hard-boiled candies 
Hard boiled lozenges with innovative taste, texture, attractive 
colours, flavours, aromas and functional benefits are gaining 
popularity in the nutraceutical and pharmaceutical market. Some of 
the leading Indian and global players in the hard lozenges segments 
are DS group, Cadbury, Nestle, Unilever, Procter and Gamble, Parry’s, 
Nutrine. Inbisco, Mondelez, Perfetti-Van-Melle, Ferrara Candy, 
Haribo, and Wrigley. The market value of hard-boiled-lozenges in 
India is estimated at around $1.3 billion reported as per express 
financial news in 2018. According to Nielsen market insight data, in 
India hard boiled lozenges is growing by 24% year to year. 
According to Technavio report the hard-boiled lozenges is having a 
global market of $1.6bn. In the USA horehound-based lozenges are 
top-selling herbal supplements used for sore throat with market 
share of $115 million in sales in year 2015. In recent years for 
product line extension, generic lozenge-based products have become 
an alternative option. It helps in enhancing the attractiveness of an 
existing product by providing appealing appearance and helps in 
positioning high-boiled lozenges as a strong and unique selling point 
different from their competitors [32]. List of some of the medicated 
lozenges is given in below table 1. 
Research work on the allopathic lozenges 
Several research articles have been published for various allopathic 
drug molecules, including efficacy, clinical study, absorption, 
bioavailability, compatibility, composition and physicochemical 
evaluation in the form of hard-boiled lozenges. Some of the most 
notable studies deals with cough drops that contains antimicrobials 
such as amylmetacresol, 2,4-dichlorobenzyl alcohol, hexylresorcinol, 
chlorohexidine, tetracycline, and benzalkonium chloride, local 
anaesthetic such as benzocaine, pain killers like non-steroidal anti-
inflammatory drugs (NSAIDs) and immunity minerals such as Zinc. A 
brief highlights of some of the research outcomes are briefed below.  
Amylmetacresol, 2,4-dichlorobenzyl alcohol and 
hexylresorcinol lozenges 
Lozenges containing amyl meta cresol, 2,4-dichlorobenzyl alcohol 
and hexylresorcinol have been shown to provide relief from sore 
throat. In vitro studies have shown their anti-viral effects in 
influenza A, cytomegalovirus, respiratory synctial virus (RSV) and 
severe acute respiratory syndrome coronavirus (SARS-CoV) that 
causes respiratory tract infections. These compounds have also been 
reported for the antibacterial, local anaesthetic and pain relief 
activity in sore throat. These activities substantiate the usage of 
these lozenges for sore throat due to viral respiratory tract 
infections. So these lozenges can be used by patients to avoid 
unnecessary usage of antibiotics [33-35]. The efficacy of lozenges 
containing combination of amylmetacresol and 2,4-dichlorobenzyl 
alcohol was clinically investigated through a multicentre, 
randomised, double-blind, single-dose study on 225 subjects. The 
lozenges exhibit analgesic and local anesthetic effects in the 
treatment group as compared to that of the controlled group. The 
results suggest that lozenges were well-tolerated and effective and 
alternative treatment option for sore throat as OTC medicines [36].  
Amphotericin lozenges 
Amphotericin lozenges have been found to be effective in the 
treatment of oropharynx with candida infection [38]. In a clinical 
study on 14 patients having haematological malignancies, 
pharmacokinetic study was done with amphotericin lozenges 
containing 10 mg of drug. The lozenges were taken 3 to 4 times a 
day by the patients. Pharmacokinetic study showed that indicates 
that systemic absorption of amphotericin increased 10 to 50 times in 
contrast to its conventional formulations. It was observed that 8.3 
To 9.9% of drug was absorbed from lozenges formulation as 
compared to its conventional dosage form in which absorption is 0.2 
to 0.9 % from a much higher dose of 2-10 g/day [37].  
Clotrimazole lozenges 
The compatibility and physicochemical evaluation of clotrimazole in 
isomalt and liquid glucose based lozenges designed for paediatric 
oral thrush. The FTIR studies indicate no interaction between drug 
and excipient and are compatible with each other. Further stability 
studies have confirmed that its stability over a period of seven 
weeks under 45 °C and 75% relative humidity condition [39].  
Albendazole lozenges 
Compatibility of albendazole in lozenges formulation prepared from 
sucrose, dextrose and sorbitol has been studied. The fourier 
transform infrared (FTIR) studies revealed the compatibility of the 
albendazole and the lozenegs base without any drug-excipient 
interactions. Further stability data confirms the stability of 
formulation [40].  
Ketoconazole lozenges 
Compatibility of ketoconazole based lozenges has been studied in 
sugar, liquid glucose-based hard boiled lozenges and found to be 
stable and compatible without any drug-excipient interactions from 
FTIR study. Ketoconazole lozenges have been found to be an 
attractive alternative formulation in the treatment of oral thrush 
pediatric population clinical trial [41]. 
Chlorohexidine and tetracycline lozenges 
A lozenge containing 3 mg of chlorohexidine and 0.2 mg of tetracycline 
per lozenge known as Drill® has been proven to show antibacterial and 
antiviral activity in vitro antimicrobial assay of S. aureus, S. pneumoniae, 
S. pyogenes, H. influenzae, B. catarrhalis and H1N1 virus. These in vitro 
tests substantiate the use of this lozenge in the treatment of upper 
respiratory tract infections such as sore throat [42].  
Tyrothricin, benzalkonium chloride and benzocaine lozenges 
Benzocaine, benzalkonium chloride and tyrothricin are having local 
anaesthetic, analgesic and broad spectrum antimicrobial activity. A 
clinical study was conducted with marketed lozenges, Dorithricin®
Zinc lozenges 
 
containing above three actives on 160 subjects with acute phrayngitis. 
The clinical results exhibited significant analgesic effect in throat pain 
relief. This indicates dothricine could be a better treatment method for 
management of acute pharyngitis and sore throat [43].  
Zinc lozeneges has been found to be beneficial in reducing the 
duration and severity of the symptoms related to common cold due 
to its antiviral activity zin ion against rhinovirus and immune 
boosting activity. Zinc is used in the form of zinc acetate, zinc 
gluconate and zinc citrate. The mechanism of action being increase 
in interferon-gamma (IFN-gamma) and inhibition of intercellular 
adhesion molecule-1 (ICAM-1) and stabilization of mast cell [44-48] 
Salbutamol lozenges 
Salbutamol sulphate based hard lozenges prepared from Isomalt and 
combination of isomalt and liquid glucose exhibits good physical 
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properties and showed delayed drug release profile for 60 min. The 
stability was confirmed on basis of a seven weeks stability studies 
without any drug and excipients interaction [7].  
Hydrochlorothiazide lozenges  
The bioavailability of hydrochlorothiazide from isomalt-moulded tablets 
and lozenges has been evaluated in healthy volunteers after oral 
administration of 50 mg dose of each of the formulation. The lozenges 
formulation of hydrochlorothiazide found to show improvement in 
bioavailability as compared to conventional tablet formulation. Superior 
bioavailability mainly attributed due to the lozeneges formulation that 
improves oral dissolution and bioavailability [49].  
Nimesulide lozenges 
Nimesulide is an analgesic and antipyretic drug used for fever and 
body pain. Hard candy-based medicated lozenges has been prepared 
and found to be having satisfactory parameters such as hardness, 
content uniformity, weight variation, dissolution rate and 
compatibility study was carried out for all lozenges formulation. The in 
vitro dissolution study showed 97.62 % drug release in 30 min [50].  
Ascorbic acid lozenges 
Akansha et al. has developed the hard candy lozenges made up of 
sugar base. The preformulation study various polymer such as 
methylcellulose, locust bean gum, HPMC, K4M and xanthan gum was 
used for controlling dissolution rate of the lozenges. The 
Formulation was found to be having satisfactory stability-indicating 
the lozenges format could be an attractive dosage form for the 
administration of ascorbic acid through oral route [51] 
Probiotic lozenges 
Probiotic bacteria such as Lactobacillus brevis and Lactobacillus reuteri 
are commonly known as good bacteria of human origin. Clinical trials 
on children with plaque and bleeding have shown that Lactobacillus 
brevis CD2 (Inersan®) lozenges improve oral health by inhibiting 
growth and adhesion of cariogenic bacteria like Streptococcus mutans. 
Another clinical trial has shown that lozenges of Lactobacillus brevis 
CD2 is effective in treatment of recurrent aphthous stomatitis with 
improvement in painful ulcers in tonsils, palates, pharynx, or tongue 
area of mouth. Sucking of probiotic lozenges containing Streptococcus 
salivarius and Lactobacillus reuteri have been found to be effective in 
relief of gingivitis, periodontitis and improvement of plaques and gum 
bleeding [52-55]. 
Research studies on herbal lozenges 
Several research studies have been published on various 
compositions of medicated hard-lozenges. An experimental clinical 
trial of essential oil-based lozenges that contain lavender essential 
oil, hop extract and lemon balm essential oil has been found to exert 
antidepressant effect. These ingredient acts through modulation of 
electrophysiology in brain [56]. Another clinical trial of effect of 
polyherbal lozeneges for relief of cough on children in comparison 
with acefyllin, aminophylline and diphenhydramine group found to 
be better with lesser side effects [57]. Sugar free lollipop prepared 
from glucyyrrhizol containing licorice extracts has been developed 
to prevent dental caries and has been proven in human trials. It acts 
through its antimicrobial effects on cariogenic bacteria Streptococcus 
mutans. This herbal lollipop could be a novel tool to promote oral 
health through functional foods [58-61]. Lozenges have been 
developed consisting of extracts of spices, ginger and garlic. The 
lozenges were found to be having anti-fungal through suppression of 
pathogenic fungus Candia albicans. This study indicates that 
lozenges can be used for non-resistant oral candidiasis.  
Trans-resveratrol lozenges 
Resveratrol, which is obtained mostly from grapes, is well known for 
its activities in atherosclerosis, diabetes, immune disorders, cancer 
and inflammatory diseases. Chemically, it is a polyphenol with 
limited bioavailability when delivered through oral route. This is 
accounted for its poor solubility in water and extensive metabolism 
in the small intestine and liver. To overcome its poor bioavailability 
resveratrol was administered through the buccal cavity as lozenges 
and it has been found to increase the bioavailability of resveratrol. 
These lozenges dissolve in mouth and enhance the absorption of the 
resveratrol as it is not entering the small intestine or liver where it is 
extensively metabolized. The onset of action was also faster when 
compared to the tablets, capsules or powders of resveratrol. In a 
clinical trial conducted on two healthy volunteers resulted in better 
pharmacokinetic properties using lozenges. Lozenges of resveratrol 
prepared using ribose, fructose and sucrose having approximately 
146 mg of resveratrol resulted in higher Cmax and faster Tmax 
compared to conventional dosage forms that are absorbed though 
the gastrointestinal tract. Cmax and Tmax for trans-resveratrol were 
325 and 332 ng/ml after 15 min in the two healthy volunteers 
studied. On the contrary, conventional oral dosage resulted in 25 
ng/ml after 48 min and 43.8 ng/ml after one hour in the two healthy 
volunteers. Hence, the lozenges of resveratrol were proved to be 
better than the other conventional oral dosage forms like tablets and 
capsules that are intended to be absorbed from the intestine [62]. 
Curcumin lozenges 
Vinay et al. have evaluated effects of curcumin lozeneges and 0.05% 
of clobetasol propionate ointment in a randomized clinical trial done 
on 30 patients diagnosed with oral submucous fibrosis (OSF), 
equally divided into two groups. The results showed that curcumin 
lozenges exhibited better effect as compared to 0.05% of clobetasol 
propionate ointment in treatment of OSF [63]. 
Echinacea purpurea lozenges 
Echinacea purpurea is a popular herb traditionally used in the 
treatment of common cold and upper respiratory tract infections. 
Dodeca-2E, 4E, 8Z, 10E/Z-tetranoic acid isobutylamide is one of the 
active constituents of the herb. The bioavailability of active 
metabolite performed on healthy human volunteers showed that the 
active constituent appeared quicker than the conventional dosage 
forms while using lozenges. Using LC-MS it was found that the active 
metabolite alkamide was detected within 10 min for 0.21 and 0.9 mg 
dose and at 20 min for 0.07 mg lozenges. This rapid appearance of 
active metabolite in blood indicates the faster action of the active 
constituent. It was also found that the pro-inflammatory markers 
such as IL-12p70, IL-8, IL-6, IL-10 and TNF were inhibited within 24 
h of lozenge administration which indicate the improvement in the 
performance of the active constituent [64-67].  
Cyanidin lozenges 
It has been observed that the bioavailability of cyanidinetaken as 
drink is approximately 0.2% and while cyanidine administered in 
the lozenge form has bioavailability of 20% based on a LC-MS based 
analysis of serumand urine sample. Therefore, lozenge form could be 
preferred administration mode for cyanidin administration [68].  
Elderberry lozenges 
From centuries Elderberry (Sambucus nigra) has been used in 
traditional medicine for treatment of cold, flu, influenza and sinusitis. 
Further clinical trial and in vitro study has reported extract of 
Elderberry against antiviral activity such as influenza-A and B and 
herpes simplex infection, and anti-bacterial activities against 
respiratory pathogenic bacteria such as Streptococcus pyogenes and 
Branhamella catarrhalis. An in vitro study has shown that flavonoids 
from elderberry bind to the surface of the H1N1 influenza virus and 
interfere with host cell receptor recognition or binding. The dark violet 
coloured berries are a rich source of anthocyanins, and phenolic 
compounds such as flavonoids. A pilot trial with elderberry extract 
containing 175 mg of flavonoids and anthocyanin in lozenges taken by 
patients with flu-like symptoms provides a beneficial effect [69-70].  
Marshmallow lozenges 
Benbassat et al. has developed the lozenges from marshmallow 
(Althaea officinalis) root aqueous extract containing polysacharides. 
The polysaccharides are reported for its antitussive effects and 
immunmodulatory effects. It reduces the local irritation and 
inflammation by forming a coating on the oropharyngeal mucosa. 
Further the root extract has been studied in albino mice and found 
to be nontoxic. The optimized formulation made up of sucrose and 
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sorbitol base was having ideal disintegration time of 6-7 minute with 
better drug release [71].  
PhytoRelief-CC
Phytorelief is a herbal-based sugar free lozenges developed by 
Alchemlife as a supplement for prevention for cold and flu. It 
contains herbal ingredient like Turmeric, Pomegranate and ginger as 
active substance having anti-inflammatory, anti-oxidant and anti-
edema properties. Slow dissolving of the lozenges in oral cavity 
leads to increase in saliva secretion which contains defence enzymes 
and proteins (lysine, human neutrophil defensins, histatins, 
Lactoferrin, Mucins, Peroxidase, α,β Defensins, Calprotectin) that 
acts as a barrier against bacterial and viral infection providing 
immunity. Further evaluation of phytorelief lozenges on human 
volunteers reveals that there was 50 percent reduction in cold 
related symptoms, complications and reduction in other treatment 
options in control vs treated groups [72-75].  
® 
Propolis candy  
Propolis is a complex product produced by the honey bees consist of 
various herbal substances such as buds and natural exudates and 
rich in natural flavonoids. Consumption of candies containing 
propolis extracts has been found to increase the salivary 
myeloperoxidase and lactoperoxidase activity that provides 
antibacterial activity [76-77]. Candies containing extracts of propolis 
has been shown antibacterial and antifungal activity on 
Aggregatibacter actinomycetemcomitans and Candida albicans 
reported to cause oral infection [78].  
Micronutrients lozenges 
A triple blind randomized controlled trial done on school children with 
candies fortified with iron and vitamin A has been showed to be effective 
in reducing prevalence of anaemia in children aged 3 to 6 y [79]. Another 
study had done with garlic and ginger extract based herbal lozenges for 
antimicrobial activity against Candida albicans, Escherichia coli and 
Staphylococcus aureus using nystatin as positive control. The formulation 
inhibited growth C albicans but not S aureus and E coli inferring that the 
lozenges can be used in non-resistant oral thrush.  
Patent review on the hard boiled candies 
Several techniques have been described in the research articles from 
academic filed and patent literature highlighting innumerable 
products, process and composition developed as hard-boiled 
lozenges. Application of patent is a basic tool for strengthening the 
mutual cooperation between academic field and corporate sectors 
supporting research and development of new drug delivery system. 
The limitation with traditional drug delivery system has triggered 
scientists to explore this platform tool, resulting in many patents in 
the area of hard-boiled candy. Some of the relevant patents are 
mentioned below on medicated HBL containing various active 
ingredients like NSAIDs, anasthetics, antacids, vitamins, nicotine, 
Probiotic and phytochemical actives. Some of the patented process 
and composition are briefly highlighted below [80].  
Pain relief candy 
Kirsty et al. in Rechitt Benckiser Health Care has developed hard-
boiled lozenges for treating in sore throat. The lozenges contains a 
non-steroidal anti-inflammatory drug (NSAID) flurbiprofen or 
ibuprofen, in molten base prepared from sugar base consist of isomalt, 
sucrose or liquid glucose, opacifiers, stabilizing agent, buffering agent, 
flavours, sweeteners, coloring agent and preservatives [81] 
Zinc and vitamin-C candy  
In an unique composition John C. Godfrey has developed a hard 
lozenges prepared from sucrose and corn-syrup that releases zinc 
ion and ascorbic acid in oral cavity. The purpose of this composition 
was to mask the aftertaste of zinc and improve the palatability [82] 
Nicotine candy  
Mehta et al. developed a novel delivery system of nicotine in a hard-
lozenges base consist of sucrose and liquid glucose. This product can 
be used to for smoking cessation in nicotine replacement therapy [83] 
Another invention by Graham HB related to development of Nicotine 
candy in cigarette shaped packing containing a series of candy [84] 
Gian Carlo Santus developed a nicotine based sugar free lozenegs in 
buffered formulation in the alkaline pH range of 7.0 to 9.0 for better 
transmucosal absorption of nicotine. At alkaline pH nicotine will 
remain in unionized form resulting in better absorption [85]. 
Antacid lozenges 
Ells Thomas and Luber Joseph have developed a hard-boiled lozenge 
formulation for treatment of gastric acid reflux diseases. The candy 
formulation consists of acid-neutralizing agent such as calcium 
carbonate or magnesium carbonate in a flavoured sugar base that 
helps in the neutralization of gastric acid [86] 
Tooth whitening application 
In recent times there is an increase in the awareness in the oral hygiene. 
Tooth whitening products are getting significant demand among 
consumers. The products are segmented as whitening gels, strips, 
mouthwash and toothpaste that helps in brightening of teeth by 
removing surface stains through bleaching action. Currently available 
OTC tooth whitening products contain bleaching agents such as 
hydrogen peroxide, and carbamide peroxide. Henryk Jakubowski has 
developed an innovative sugar free candy composition that contains 
citric acid, calcium peroxide, sodium bicarbonate. It releases hydrogen 
peroxide when calcium peroxide reacts with citric acid in saliva. It makes 
the teeth white by removing tartar, plaque, calculus, and stains [87, 88] 
Candies for dental caries 
The invention deals with preparation and composition of hard 
candies for remineralisation of dental caries and dental plaques. The 
candies contain a therapeutically required amount of calcium and 
phosphate salt such as calcium glycerophosphate, calcium lactate, 
calcium gluconate, α-tricalcium phosphate, calcium 
glycerophosphate, sodium dihydrogen phosphate dihydrate in sugar 
free or sugar-based candy. The candies acts through deposition of 
calcium and phosphate ions into oral cavity and on dental plaque 
resulting in remineralisation and repair of the cariogenic teeth [89] 
Anaesthetic property 
The anaesthetic candy contains active ingredient lidocain and 
benzocaine in a hard candy base prepared from either of sugar or 
sugar free base. The invention is for purpose of oral pain relief from 
sore throat, cough and canker sores [90] In addition to above 
described patented products there are numerous patents have been 
described. Below is the list (table 2) of few patents on functional and 
medicated innovations on hard boiled lozenges. 
Formulation 
The hard boiled lozenges are having a weight ranging from 2.5 to 3.5 
gram with the active pharmaceutical ingredients. Hard boiled lozenegs 
are formulated using various components such as lozenegs base like 
sucrose, liquid glucose, isomalt, sorbitol; binder such as gum acacia, 
methyl cellulose; FDandC colors; flavouring agents; humectants like 
glycerin, propylene glycol and organic acids [11]. The general 
composition of the hard boiled candies is shown in table 3. 
Bulking agent and sweeteners 
Bulking agent and sweeteners are the major component of hard-boiled 
lozenges. They are generally consists of liquid glucose, sucrose, 
fructose, dextrose, sugar free low-caloric substances like isomalt, 
erythritol, sorbitol, lactitol and maltitol. The liquid glucose made from 
acid, enzyme and acid-enzyme combination hydrolysis of corn starch. 
It is available in various grades depending on the dextrose equivalent 
(DE) such as 42-DE and 60-DE. The major role of liquid glucose in hard 
lozeneges is to control crystallization, add body, to adjust the 
sweetness level. As the sugar based candies poses the risk of dental 
caries, sugar free lozenges made of maltitol syrup, isomalt, aspartame, 
plant based sweeteners such as monk-fruit sweeteners and stevioside 
are being recently explored as a substitute for sweeteners. The 
sweetness index of erythritol, Isomalt, Sorbitol, xylitol, aspartame and 
stevioside are 0.7, 0.4, 0.5, 0.95, 200 and 300 as compared to sucrose 
with relative sweetness of one [91]. 
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Table 2: Patented technology on hard-boiled lozenges 
S. No. Title  Patent number Active ingredients  Therapeutic indication 
1 An anti-motion sickness throat 
lozenge 
CN 105412876 A 
20160323 
Ginger extract  Anti-motion sickness 
2 A throat lozenge for treating acute 
pharyngitis, and its preparation 
method and application thereof 
CN 104840566 A 
20150819 
Nepalese polygonum, Auricled, Hedyotis, 
Bulleyanachang, 
Acute pharyngitis 
3 Herb extract-containing lozenge 
composition for treating inflammatory 
diseases of the mouth and pharynx 
WO 2010003472 A2 
20100114 
Herbal extracts  Inflammation in mouth and 
pharynx, cough, and upper 
respiratory tract infection  
4 Herbal formulations comprising 
cineole, eugenol, and vasicine as 
cough lozenge 
WO 2006067600 A2 
20060629 
Clove, Adhatoda vasaka, Eucalyptus oil Coughs and sore throat.  
5 Process for addition and 
stabilization of vitamin-C in a hard 
candy-like comestible 
USP 4692339 Sodium ascorbate and ascorbic acid  Antimicrobial and 
nutritional supplement 
6 Herbal cough candy and process for 
the preparation of the same 




Vitis vinifera, Terminalia chebula, Piper 
longum, Glycyrrhiza glabra, Cinnamomum 
zeylanicum, Melaleuca leucodendron, 
Eucalyptus oil, sugar and liquid glucose 
base 
Minor throat infections and 
laryngitis 
7 Synergistic herbal blood detoxifier 
formulation 




Echinacea purpurea leaves, Andrographis 
paniculata 
leaves, Boerhaavia diffusa whole plant, 
Arctiumlappa root, Rubia cordifolia root, 
Pothosaureus, leaves of Ixora coccinea, 
stems of Jacaranda mimosa folia, roots of 
Hemidesmus indicus, the heartwood of 
Acacia catechu, stem of Cassia biflorain, 
leaf of Cassia seamia and flower of Dahlia 
pinnata. 
Blood purification  
8 Therapeutic herbal lozenge 
composition 




Osha root, lobelia herb. licorice root, 
yerba santa leaf, eyebright herb, cats 
claw, rosemary, ginger, green tea leaf, 
grape seed, and peppermint 
Enhances respiration 
9 Development of anti-cough, anti-
tussive and throat soothing herbal 
formulation 




Extract of Piper cubeba, 
Glycyrrhiza glabra, Acorus calamus, 
Alpinia galanga, Zingiber officinale 
Anti-cough, anti-tussive 
10 Herbal formulation of Gymnema 
sylvestre as a dietary aid 




Gymnemic acid  
 
Dietary aid for controlling 
sweet intake 
11 Candy for larynx CN 200510024625 licorice, dried tangerine peel, boat-
fruited sterculia seed 
Cough relief  
12 Process for making a hard-candy-
based oral pharmaceutical lozenge 
containing an antacid. 
US5616340 (1997) 
US5399354 (1995) 
calcium carbonate or magnesium 
carbonate 
Antacid  
13 Production process for NSAID-
containing lozenges, their 
compositions, their medicinal use 
US10328039 (2019) NSAIDs  Sore throat  
14 Medical cannabis lozenges and 
compositions there of 
US9504723 (2016) Cannabidiol and tetrahydrocannabinol Psychoactive drug 
15 Suckable-flurbiprofen lozenges for 
treatment of sore throat 
US 6166083 (2020) Flurbiprofen Sore throat 
 
Table 3: Basic composition of a typical sugar and sugar free hard-boiled lozenges [92, 93] 
Sugar-based hard-boiled lozenges  
S. No Components  Concentration (%w/w) 
1 Sucrose 58-60 
2 Liquid glucose  38-40 
4 Active Ingredients  1-3 
5 fruit acids 0.5 
6 Flavours and Colours q. s. 
Sugar-free hard-boiled lozenges  
S. No Components  Concentration (%w/w) 
1 Isomalt  97-100 
2 Active Ingredients  1-3 
3 Fruit acids 0.5 
4 Artificial sweeteners  q. s. 
5 Flavours and Colours q. s 
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Active pharmaceutical ingredients  
Various active pharmaceutical ingredients can be incorporated into 
the hard lozenges. The commonly used active ingredients are having 
properties such as local anaesthetics, antiseptics, antimicrobial, anti-
viral, analgesics, and demulcent properties. Peppermint oil, l-menthol, 
eucalyptus oil, benzocain, amylmetacresol, hexylresorcinol, 
cholohexidine hydrochloride, diphenhydramine hydrochloride, 
cetylpyridinium chloride are used in many over the counter (OTC) 
lozenges used for sore throat and cough. Some of the lozengescontain 
pain killers such as flurbiprofen. One of the lozenges called 
ActiqTM
Hydrophilic polymers 
contains an opioid analgesic fentanyl. Zinc gluconate lozenges 
and zinc acetate lozenges are common zinc based lozenges used in 
various common cold symptoms. Many of the lozenges contain various 
herbal extracts such as extract of liquorice, Echinacea sp. Elderberry 
extract having anti-viral and anti-microbial properties [47, 48, 99].  
Addition of hydrophilic polymers prolongs oral retention time of 
hard boiled candies by delaying the disintegration time of lozeneges. 
The most commonly used polymers are gum-acacia, hydroxyl 
propylmethyl cellulose, xanthan gum, guar-gum, and carboxy methyl 
cellulose [39, 92]. 
Flavours 
Flavours are needed to improve the palatability by masking bitter 
and nauseating taste of the incorporated drug. Further the flavour 
plays to attract the consumers and to distinguish the products. 
Amount flavour needed depends upon its nature and strength. 
Generally flavours are either used in single or as fusion flavours with 
combination of two or more flavours. The common flavours used are 
peppermint menthol, eucalyptus oil, ginger, and various fruit 
flavours. Menthol is a cooling flavour that provides a cooling effect 
by binding to cooling receptor called TRPM8. Schober AL and 
Peterson DG has studied with combination two flavours 1-8 cineole 
and menthol in hard lozenges by breath analysis and sensory time-
intensity, and found that the intensity of the flavour is affected by 
interaction of flavoured compounds. It has been observed that, 
single flavour lozenges have a better release rate as compared to the 
mixture. For evaluation of flavour and to discriminate various types 
of the flavours electronic tongue is used [91, 100] 
Humectants 
Humectants such as invert sugar, glycerine are used in the lozenges 
to prevent from drying brittleness and to enhance the cold flow 
properties. Most commonly used humectants are glycerine and 
propylene glycol in 0.5 to 2% s [101].  
Organic acids and buffers 
Various acidulents and buffers such as potassium carbonate, 
potassium bicarbonate, sodium carbonate, sodium bicarbonate, 
potassium citrate, sodium citrate, and their combinations, various 
organic acids like citric acid, tartaric, malic acid, ascorbic acid, lactic 
acid, gluconic acid are used in hard candies to stimulate saliva 
secretion in buccal cavity which facilitate the dissolution of lozenges 
in the buccal cavity. Further, these ingredients provide ideal pH in 
buccal cavity to facilitate absorption of active ingredients through 
buccal mucosa. Further uses of acidulents also provide a persistent 
taste and strengthen the flavour and compensate the aftertaste high-
intensity sweeteners in sugar-free lozenges [15, 97, 102].  
Colouring agents 
Colouring agents under FD and C and customized food-grade colours 
are used for the desired shades of the colour. 
Manufacturing procedure 
The hard-boiled lozenges are solid amorphous products with a 
glassy appearance prepared by heating, melting and quick 
congealing method into the desired moulded shape. They are either 
made of sugar such as sucrose and liquid glucose or may be sugar-
free prepared from isomalt. A general manufacturing process of both 
sugar-based and sugar-free hard lozenges is mentioned below.  
Sugar-based hard lozenges 
The basic components of hard lozenges are sugars such as sucrose, 
fructose, glucose and liquid glucose or maltose syrups, colours, 
flavours and acids. Commonly the hard-boiled lozenges are made up 
of a mixture of sucrose and liquid glucose in proportion ranging 
from 40:60 to 65:35 by weight. The general process of making hard 
lozenges involves mixing of sugar and liquid glucose with excess of 
water and dissolving sugar under heat to make homogenous syrup 
mass. It is concentrated at temperature of 130-150 °C under vacuum 
and stem pressure to reduce the moisture content below 1-2% [68]. 
Then molten mass is cooled to temperatures of 90 to 115 ⁰C, during 
this time other components such as colours, flavours, acids, 
stabilizers and active ingredients are added and homogenously 
mixed and subsequently put into mould of proper shape and passed 
through the cooling tunnel at temperature of 25-30 ⁰C under relative 
humidity of 40-50%. The temperature at which the molten lozenge 
matrix gets transformed to amorphous glassy state from liquid is 
knownas glass transition temperature (Tg). Colours and flavours are 
incorporated homogenously in the hard lozeneges in its glassy stage. 
Tg value decreases with increase in water content and with increase 
in the molecular weight of sugars used in the candy. Tg value of some 
of the common confectionary sweeteners such as fructose, glucose, 
lactose, maltose, sucrose, sorbitol, xylitol, and maltitol are 5-10,31, 
101, 87, 62-70,-9,-29, 39, 63.6 and that of 42 DE and 20 DE liquid 
glucose are 79 and 139 °C, where DE stands for dextrose equivalent. 
But in the hard lozenges prepared from mixture of sweeteners value 
of Tg depends of the ratio of the different sweeteners mixed and have 
Tg value in between the sugar components used in the mixture. 
Differential scanning calorimetry (DSC) is the most common method 
to measure the glass transition temperature [76].  
Sugar free hard lozeneges 
Commonly sugar-free hard-boiled lozeneges are made up of maltitol 
syrups, sorbitol syrup and powdered maltitol, mannitol, erythritol 
and isomalt. Isomalt is among the most predominantly used base for 
the manufacture of sugar-free lozeneges. The basic composition of 
lozeneges consists of isomalt with the flavours, colours, acids and 
intense sweeteners such as sucralose and acesulfame K. The isomalt 
and water in ratio of 75:25 is boiled under vacuum to evaporate the 
water content to 2.5% of less cooled and moulded to room 
temperature with the addition of various substances such as 
sweeteners, acids, flavourings, colourings, acids, herbal extracts and 
pharmaceutical active ingredients. Because of the low solubility of 
isomalt, higher temperature of 150-200 ⁰C and more time and high 
quantity of water is needed for the dissolution of isomalt [60, 63]. 
Other process is similar to above manufacturing procedure of sugar 
based hard lozenges. The isomalt lozenges have advantages as 
compared to the sugar-based lozeneges due to their low water 
solubility leading to extended action and slow releases of the actives 
[94, 103]  
Critical control parameters 
The quality of lozenges such as hardness, texture and stability 
depends on various parameters such as quality of water, pH of water 
used in the formulation, cooking temperature during the 
preparation of candy. Below are mentioned some of the critical 
parameters of the hard-boiled lozenges. 
Residual moisture content 
In the manufacturing procedure of hard-boiled lozenges water is 
used for dissolving the sugar and other components used in 
formulation. All the materials should be completely dissolved in 
order to prevent the crystallization of the sugars in the finished 
product as well during further processing. The water should be 
reduced in the final formulation to 1-2 percentages. The percentage 
of water in the hard-boiled lozenges affects texture, shelf life and 
microbial stability. Higher moisture content leads to soft texture, 
graining or stickiness, loss of flavour, growth of microbes such as 
yeasts, molds and bacteria for hard lozenges. Further higher 
moisture content leads lower glass transition temperature, which 
affects the shelf life of hard lozeneges [103].  
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pH of water 
pH of water is one of the critical attributes that affects the texture 
and appearance of the hard lozenges. For ideal glassy appearance 
the pH of water should be neutral. Acidic water with pH below 6.0 
along and high processing temperature during manufacturing 
process results in increase of reducing sugar due to inversion 
causing discoloured and sticky texture to lozeneges [97-98].  
Storage temperature of hard boiled lozeneges 
For desired shelf life the hard lozeneges should be storage 
temperature should be below their glass transition temperature. As 
the hard lozenges are thermodynamically unstable amorphous 
products, storage condition above the glass transition leads to 
crystallisation of sucrose in hard lozenges leading to lose its glassy 
appearance and texture. Ideally high humidity and temperature 
should be avoided for storage of hard boiled lozeneges [97, 98].  
Evaluation of hard boiled lozenges 
Characterization and evaluation of the hard boiled lozenges is done 
by following tastes and methods.  
Organoleptic evaluation 
Human taste panels are used for evaluation of physical appearance 
such as uniformity of colour, odour, shape, size and sweetness. In 
vitro taste evaluation is performed by using electronic tongue 
equipped with taste sensors or. One of the electronic taste sensing 
system is SA402B equipped with sensors imitating the taste stimuli 
and sensory signals that provides an understanding of taste 
qualities. This is also used for taste evaluation of other products 
such as food, beverages, and pharmaceuticals [105].  
Physicochemical quality control parameters of the lozenges 
It includes quality control parameters such as pH, size, weight 
variation, hardness or crushing strength of lozenges, Friability test, 
content uniformity and time for dissolving of the lozenges.  
pH value  
he pH value of the lozenge is determined by dissolving one lozenge 
in 100 ml of distilled water and measuring by pH meter electrode. 
Determination of pH is one of the important parameter as extreme 
acidic and basic pH leads to irritation of buccal mucosa as well the 
pH also affect the taste of lozenges.  
Size 
The dimensional parameters such as thickness and length are 
measured by micrometer or digital slide caliper. The parameters are 
controlled within a parameter of±5% variation from standards and 
expressed in millimetre.  
Weight variation 
As per the method described in USP weight variation testis done by 
weighing 20 lozenges individually on an electronic balance, 
calculating the average weights and comparing with individual 
weights. The measure of weight variation is expressed as percentage 
using the below formula. According to USP not more than 2 of the 
individual weights of lozenegs should deviate from average weight 
by more than 5% [106, 107].  
Hardness test/Crushing strength 
The hardness of the lozenges measures the force required to break the 
lozenges diametrically into halves by compression with a coiled spring 
and is expressed in kg/cm2
Friability test 
. The hardness is measured by using hardness 
tester like Pfizer or Monsanto and electromechanical equipment EHT-
5PR. Some of the factors that affect the hardness are geometry, 
dimension, orientation and composition of formulation [106].  
Friability test is performed to access the effect of friction, shocks, 
vibration, on capping or breaking of lozeneges. Roche-friabilator is 
used for this test. According to USP-NF the lozenges complies with 
the test if friability loss is less than 1% of their weight [106].  
Uniformity of content 
To ensure the efficacy of the lozenges the quantity of the active drug 
needs to be monitored from lozenges to lozenges and from batch to 
batch. Content uniformity is determined by using suitable analytical 
methods such as HPLC, HPTLC or GC. According to USP the 
formulation complies with the test if individual content is between 
85 percent to 115 percent average content [106, 108]. 
Ash value 
Ash value indicates presence of the inorganic substance in the 
product. As per FSSAI standards of India sulphated ash of lozeneges 
should be not more than 2.5% and acid insoluble ash should not be 
more than 0.2 percent.  
Mouth dissolving time 
USP-disintegration apparatus is used for this test. To determine the 
dissolution time one of lozenges is placed in the tube of basket rack. 
Then the basket rack is immersed in 900 ml vessel containing buffer 
solution at pH of 6.8 maintained temperatures of 37 °C equivalents 
to buccal cavity condition. The basket assembly is subjected to up 
and down motion with a motor driven device through a distance of 
5-6 cm at frequency of 28 to 32 cycles per minute. Perforated plastic 
discs are used to prevent the floating of lozenges. The apparatus is 
operated for 30 min. To comply the test, lozenges must dissolve 
completely without any particles on 10-mesh screen within 30 
minute. Normally the dissolution time depends on the composition 
of the hard boiled lozenges and it varies from 6 to 10 min. Further 
human panel can be used to determine the actual dissolution time of 
the hard boiled lozenges [11, 109].  
Dissolution 
Dissolution experiment is performed to study the drug-release 
profile and solubility of the final formulation. Generally the 
dissolution is done in USP apparatus II in simulated saliva fluid at 
temperature between 33-37 °C and pH of 6.8 related to the buccal 
conditions. The composition of some dissolution medium suitable 
for lozenges is given below [11]. 
Composition-I 
Mashru et al. has reported the dissolution medium for a salbutamol 
sulphate oral fast dissolving film. The composition for simulated 
salivary fluid consist of components sodium chloride (8 gm) 
ptassiumdihydrgen phosphate (0.190 g) Sodium hydrogen 
phosphate dihydrate (2.984 g), demineralized water (1000 ml) and 
adjusted to pH of 6.80 with Phosphoric acid [11].  
Composition-II 
According to German Drug Codex (DAC) and New German Formulary 
(NRF) the artificial saliva consist of sodium chloride (0.085 g), 
potassium chloride (0.120 g), Sodium monohydrogen phosphate 
dodecahydrate (0.250), Sorbic acid (0.1 g), Calcium chloride (0.15%) 
or Magnesium chloride (0.05%) (10 g), carmellose sodium (0.5 g), 
70% sorbitol solution (4. g), demineralized water (84.645 g) [11]. 
Composition-III 
Yingyi M et al. have described the preparation method of artificial 
saliva with 3% mucin with pH 6.8 to simulate buccal condition. It 
consist of sodium chloride-NaCl (1.594 g), ammonium nitrate-
NH4NO3 (0.28 g) Potassium di hydrogen phosphate-KH2PO4 (0.66 
g), potassium chloride-KCl (0.202 g), potassium citrate-K3C6H5O7. 
H2O-(0.08 g), sodium salt of uric acid (C5HN4O. Na(0.021 g), urea-
H2NCONH2 (0.198 g), sodium salt of lactic acid-C3H5ONa (0.146 g), 
porcine gastric mucin-Type-II (30 g),in 1000 ml of water [91]. 
Dissolution studies for some of the lozenges as per FDA monographs 
and other research reports are described below.  
Zinc and vitamin-C lozeneges 
It is used for systemic action. In vitro dissolution study of this 
lozenge is performed in USP dissolution test apparatus-II (Paddle 
type) at 75 rpm in 900 ml of 0.1 N hydrochloric acid. The sample is 
withdrawn after 60 minute for testing [11]. 
Umashankar et al. 
Int J App Pharm, Vol 13, Issue 2, 2021, 1-13 
9 
Nystatin lozeneges 
Nystatin is an antimycoticpolyene antibiotic used for treatment of oral 
candidiasis. In vitro dissolution study of this lozenge is performed in 
USP disintegration apparatus at 29-32 rpm in demeralized water. The 
sample is withdrawn after 90 minute for testing [11].  
Fentanyl citrate lozeneges 
Fentanyl citrate is a pain killer used for systemic action. In vitro 
dissolution study of the lozenge is performed in USP dissolution 
apparatus II (paddle type) at 175 rpm. Dissolution medium used was 
0.1 M phosphate buffer with pH 6.8 and the sample was withdrawn 
in interval of 5, 10, 20, 30 and 40 min for analysis [11].  
Nicotine polarcrilex lozeneges 
It is used for systemic action in order to stop smoking. In vitro 
dissolution study is carried out USP dissolution apparatus (basket 
type) at 100 rpm. Phosphate buffer with pH 7.4 is used as 
dissolution medium for study of drug release and the sample is 
withdrawn at time interval of 0.5, 1, 2, 3, 6 and 8 hour [11].  
Itraconazole lozeneges 
Deepika M et al. have reported dissolution study for Itraconazole 
lozenges formulated for oropharyngeal candidiasis. They have used 
USP dissolution test apparatus type II (paddle type) at 100 rpm. 
Phosphate buffer with pH 6.8 at 37±0.5° Ccontaining 2% SLS was 
used as dissolution medium for in vitro drug release studies. The 
sample was analysed by using UV-visible spectrophotometer at 262 
nm to calculate the drug release [6].  
Clotrimazole lozeneges 
Nagoba SN et al. have performed the dissolution study of the 
clotrimazole lozenges made from sugar and liquid base. 100 ml of 
phosphate buffer (pH 6.5) in a beaker stirred at 100 rpm was used 
as dissolution medium. 5 ml of samples were withdrawn at time of 
interval of 5 minute and analyzed by UV-visible spectrophotometer 
at 272 nm [35]. 
Albendazole lozenges 
Neha D et al. have carried out the dissolution of the hard boiled 
lozenges formulated from sucrose, dextrose and sorbitol solution. In 
vitro dissolution study of the lozenge is performedin USP dissolution 
apparatus II (paddle type) at 100 rpm. Phosphate buffer with pH 4.5 
at 37±5 °C is used as a dissolution medium and the sample is 
withdrawn in time interval of 5 min for 30 min. Drug release from 
the lozeneges was analyzed by UV-visible spectrophotometric 
methods at 295 nm [39]. 
Evaluation of buccal permeation 
As the lozenges formulation intended to be slowly dissolve in the 
mouth for release of drug in buccal cavity. Buccal delivery is 
having the advantage of bypassing the gastrointestinal and 
stomach drug degradation and reducing first pass effects. 
Evaluation of mucosal permeability is one of the vital parameter 
for pharmacokinetic study of the drug before the market approval. 
On the basis of physiological structure of human buccal 
transmucosal membrane various methods are reported in the 
literature for in vitro evaluation of buccal mucosal absorption 
study.  
  
The commonly used methods are animal buccal mucosa, animal 
non-buccal mucosal models, cell models, biomimetic barrier 
model, and AMI-system and diffusion cells. The classification of 
various permeation models used for permeation study is 
mentioned in table 4 this method provides insights about extent of 
drug delivery, rate of drug absorption, permeation, and 
bioavailability across the buccal mucosa [110, 111]. 
Table 4: List of in vitro permeation model 
S. No. Permeation 
model  
Description and characteristics  References  
1 1. Animal buccal 
mucosa 2. 
Porcine and bovine buccal mucosa   
Nonkeratinized and similar physiological structure, thickness, morphology and composition to 
human buccal mucosa 
[110, 111] 
2 1. Animal non-
buccal mucosa  2. Chick chorioallantoic membrane: The composition is similar to human buccal mucosa except 
absence of mucous layer  
Porcine esophageal mucosa: histology and lipid composition is similar to human buccal mucosa  
3. Used as substitute when porcine buccal mucosa is not available  
 
[110, 111] 
3 1. Cell model  
2. Have morphological and physiological function similar to human buccal mucosal epithelial cells  
Hamster cheek pouch cell, TR146, EpiOralRTM 




4 1. Biomimetic 
barrier model 2. Some of the models are Parallel Artificial Membrane Permeation Assay (PAMPA), Phospholipid 
Vesicle-based Permeation Assay 
It is an artificial non-tissue and non-cellular model consist of artificial membrane and lipids. 
(PVPA), Permeapad® and Artificial Membrane Insert System (AMI-system). 
3. Used for study of passive transport of the drug  
 
[111] 
5 1. Diffusion cells 
2. Used for study of rate of permeation of drugs  
Various types includes vertical diffusion cells (Franz diffusion cell, Flow-through diffusion cell) 




Methods of characterization 
Thermoanalytical methods 
Differential scanning calorimeter (DSC) is the used to study the 
thermodynamic properties drugs, drug and excipients compatibility, 
and crystal nature of the drug. Appearance of the endothermic peak 
of the drug and excipient at its melting point indicates the 
compatibility of drug with formulation. The change in melting point 
of the active ingredients confirms potential interaction between 
drug and excipients. The commonly used instruments used to study 
the thermodynamic properties are DSC (PerkinElmer Inc.,), DSC-
2010 (TA instruments) and Shimadzu DSC-60 plus. The analysis is 
performed by taking 4-6 mg, of indium pan and heating with 
temperature gradient depending on melting temperature under 
nitrogen or argon flow [96-112]. 
Powder X-ray difractometry (PXRD)  
Powder X-ray diffraction (PXRD) is used for study of crystalline or 
amorphous nature of drug molecules. XRD confirms possible change 
in the polymorphism of the drugs after processing. The presence of 
the intense sharp peaks indicates crystal nature of the drug while 
reduced intensity of the peaks indicates amorphous nature of drug 
after dispersion. The commonly used instrument for XRD study are 
D8 Advance X-ray diffractometer (Bruker, Germany) and X’pert Pro 
Analytical (Netherland) [92-117]. 
Umashankar et al. 
Int J App Pharm, Vol 13, Issue 2, 2021, 1-13 
10 
Fourier transform infrared spectroscopy (FTIR)  
Fourier transform infrared spectroscopy (FTIR) is performed to study 
the drug-excipient interaction studies. The FTIR fingerprint of pure 
drug is compared with its finished formulation. Similarity of 
characteristic peaks of drug with its formulation indicates any physical 
and chemical interaction between drug and excipients. The instrument 
used are PerkinElmer in KBr pellets methods or by Nicolet™ iS50 FTIR 
(thermo scientific) or Bruker alpha II FTIR in ATR mode with diamond 
crystal using direct sample for analysis [119]. 
Solid-state nuclear magnetic resonance (NMR) 23+ 
Solid-state NMR technique is used for study drug properties drug at 
atomic level and to study crystalinity nature of the materials. Solid-
state NMR provides information about chemical stability of drug and 
excipients that helps in study of degradation processes of drugs in 
the solid state. SS-NMR is also used to determine the residual water 
molecules that are present in the interior of crystal lattice of the 
formulation [119].  
Microscopy 
Microscopy method is used to study crystals or amorphous nature of 
materials, surface morphology, size, shape and distribution of drug 
in the formulation. Scanning electron microscopy (SEM) is used for 
study of distribution pattern of the drug within the lozenges and to 
analyse microstructure of the lozeneges. The common instruments 
used for it are FEI-Quanta 450 and EVO-18 Zeiss microscope [115]. 
Moisture analysis  
Moisture content is a critical parameter for quality of the lozenges 
and affects its stability and shelf life. At lower moisture content 
sucrose within lozenges remain in an amorphous or glassy state. 
Storage temperature above its glass transition temperature causes 
crystallisation of sucrose affecting the texture and glassy appearance 
leading end of shelf life. Excess moisture also affects microbial 
stability, enzymatic and non-enzymatic reactions during storage. For 
better shelf life the moisture content of a hard candy should be in the 
ranges of 2-5%. Various methods used for moisture analysis are loss 
on drying method, Nuclear Magnetic Resonance (NMR) and Near-
infra red technique (NIR), and karl-fischer titration. In NIR Water 
gives signals at 1450 and 1940 nm, based on different vibrational 
modes, which are used to quantify the water content [96].  
Taste evaluation 
Taste is one of the most important organoleptic properties that 
influence patient acceptance and compliance. Therefore taste 
evaluation is one of the important parameter of quality control. 
Taste evaluation is done both by electronic taste sensing system and 
human taste penalists. But for the drug with narrow therapeutic 
index the human penalists is not suitable so electronic tongue is 
preferred. The electric tongue is equipped with a taste sensing 
system having sensors for various taste signals such as umami, 
saltiness, astringency, bitterness and sourness [120, 121]. The Insent 
taste sensing system SA402B was used equipped with 7 sensors of 
various taste stimuli has been found to be one of promising tool for 
taste evaluation of complex products [122, 123]. 
Stability studies of hard boiled lozenges 
The shelf life of the herbal drug based hard lozenges is determined 
by conducting the stability studies as per the ICH guidelines. It helps 
to determine the length of time that substance maintains its 
acceptable level of quality without undesirable physicochemical 
qualities and safe microbial limits. The stability parameter includes 
total bacterial count, total yeast and mold, pathogens such as 
Escherichia coli, salmonella species, Staphylococcus aureus, 
Pseudomonas species, and physical parameters like texture, color, 
odour, taste, hardness, stickiness, moisture content, crystallization, 
and assay of the active ingredient [124-125].  
Packaging of hard boiled lozenges  
Packing conditions are critical for storage, protection and stability of 
the dosage form. As the hard boiled lozenges are extremely moisture 
sensitive it needs immediate packing after cooling and moulding for 
protection from light and moisture. Some of the common packing 
material used for hard boiled lozenges multilayer laminate in 
different combination like polyester (PET), low density poly 
ethylene (LDPE), metallized polyester (MET PET), and 
polypropylene (PP) aluminium foils, pouch, and blister packs made 
from opaque PVC with aluminium foil. Among the above packing 
materials aluminium foil has been found to most effective in protection 
for the active drug. For secondary packing HDPE and PET bottles are 
also used as suitable material. While packing the environmental 
conditions in the packaging area should be maintained at optimum 
humidity and temperature to prevent sticking by moisture. For 
example isomalt lozenges need 40 to 50%RH at 20 to 25 °C. The 
printing ink should be non-toxic and utmost care should be taken to 
prevent contact of ink with the product [10].  
Regulatory aspects of hard boiled lozenges  
All the ingredients used for lozeneges formulation should be of 
pharmacopoeia quality. For example Isomalt is approved under FDA 
as an inactive ingredient. Isomalt is available in pharmaceutical grades 
according to the monograph on in the European Pharmacopoeia and 
USP-NF. Further the product should comply with the various required 
parameters such as heavy metal limits for Arsenic(As), Lead (Pb), 
Cadmium(Cd), Mercury(Hg), and microbial contaminant such as total 
microbial plate counts, total yeast and molds, pathogen count such as 
Escherichia coli, Enterobacteriaceae, Coliforms, Pseudomonas 
aeruginosa, Staphylococcus auerus, Salmonella sp., aflatoxin, as per the 
pharmacopoeial standards. For examples as per the Ayurvedic 
Pharmacopoeia of India the heavy metal content for Arsenic (As), Lead 
(Pb), Cadmium (Cd) Mercury (Hg) should be 3 ppm, 10 ppm, 0.3 ppm 
and 1 ppm respectively, total microbial plate count (105cfu/g), total 
yeast and mold (103cfu/g), aflatoxin-B1, B2, G1 and G2 limit is (0.5 
ppm, 0.1 ppm, 0.5 ppm, and 0.1 ppm respectively) [126]. List of 
ingredient composition of the product should be mentioned on the 
product label. The lozenges having therapeutic claim should be 
supported by relevant clinical trials such as lozenges with therapeutic 
claims like, sore throats, beneficial for the respiratory system should 
be substantiated by relevant clinical trials [127].  
CONCLUSION  
The hard-boiled lozenges are having immense potential as an 
attractive, differentiated and efficient drug delivery dosage form. 
Various clinical trials have confirmed better bioavailability and 
improved absorption of drugs for both local and systemic effects. 
The present manuscript highlights various innovative patented 
application as well academic publications on hard-boiled lozenges. 
Application of hard-boiled lozenges for throat infection, cough relief, 
anti-infective, antifungal, Immunity boosting, smoking cessation, 
antacid, oral care, dental care and tooth whitening are some of the 
exciting application. The article further provides information of 
various commercial products available in the market in form of 
hard-boiled lozenges. So the HBL can be an alternative platform 
technology for manufacturing of pharmaceutical dosage for drug 
delivery through oral routes for the new as well the existing active 
pharmaceutical ingredients. Research results and current market 
status showed promising potential in high patient compliance, 
enhanced absorption, avoidance of gastrointestinal or hepatic first 
pass metabolism, improved oral bioavailability of poorly water 
soluble drugs in HBL dosage form. For future development more 
scientifically rigorous and adequately studies are needed for better 
study of the bioequivalence, more relevant in vitro dissolution study, 
drug metabolism and drug-excipient interactions in the area of the 
hard boiled lozenges. Therefore exploration in this area will open a 
new gateway for development of hard boiled lozenges as powerful 
drug delivery technology.  
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